
One of our McKesson experts discusses the importance of staying informed as 340B changes continue to unfold.
Our 340B experts explore ways to identify gaps in your 340B performance and offer solutions.
Date
May 19, 2022
By: Christopher Shain, Heather Easterling and Andrew Wilson
Read time: 1 minute
Many health systems may struggle to manage their 340B business performance because understanding their metrics requires data and analysis that aren’t easily available. Watch the 340B Tips, Tricks, and Traps webinar as we explore ways to leverage analytics with revenue cycle and generics purchasing to identify gaps in your 340B performance that can help you make informed decisions.
One of our McKesson experts discusses the importance of staying informed as 340B changes continue to unfold.
At this year's event, our experts heard from health systems who may be underutilizing available tools and resources in 340B program management.
Our experts continue shaping industry conversations through regular conference and event engagements, like the HealthTrust University 340B Summit.
In a unique, retreat-style setting, health systems leaders had close conversations around best practices, wins, struggles, and solutions.
As the infusion services market continues to evolve and challenge one of health systems’ longstanding service lines – new opportunities are also emerging.
Drug shortages have decreased, but supply chain complexity requires ongoing innovation and resilience to maintain drug availability.
Learn how McKesson is helping advance the 340B program through strategic customer engagement and insights.